Together we can develop novel treatments for rare diseases
Supercharged drug discovery and development
Our AI technology and approach means we can discover and develop unique therapeutic opportunities faster. By combining our expertise with your scientific insights, disease knowledge and assets, we can accelerate treatments to rare disease patients.
Partner with us
Combine your research with our drug development expertise and resources to bring new treatments to rare disease patients. Our dedicated team of clinical, commercial and regulatory experts can progress your research towards clinical trials and on to patients in need. We have an experienced team of drug development experts and supporting infrastructure.
Who we work with
We are interested in exploring opportunities to enhance and co-develop existing rare disease assets. We also work with partners interested in co-developing our treatments – taking these through the clinic and on to patients.
We are looking to in-license small molecule drugs with evidence of efficacy in rare diseases. These drugs will ideally have a target indication identified and have progressed through the preclinical stage.
Discover new treatments for diseases of interest. Healnet enables us to identify treatments to enhance existing drugs or identify additional indications for existing molecules.